Wed.Jan 25, 2023

article thumbnail

Smart Injector Insulin Pen Device, Mallya, Cleared by FDA

Drug Topics

Mallya can provide convenience for insulin pen users; however, it has yet to be released in the United States.

FDA 469
article thumbnail

Wave of leading medical schools pull out of U.S. News' annual rankings

Fierce Healthcare

Wave of leading medical schools pull out of U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Major study on DMT shows promise for depression

European Pharmaceutical Review

The first major study on the efficacy of DMT in treating any mental health condition showed a remission rate of 57 percent following a single dose, in a Phase IIa trial for major depressive disorder (MDD). “SPL026 (intravenous DMT) with supportive therapy was shown to have a significant antidepressant effect that was rapid and durable, with a remission rate of 57 percent at three months following a single dose of SPL026,” stated Dr Carol Routledge, Chief Medical and Scientific Officer at Small P

Labelling 133
article thumbnail

Finding Pharmacy Solutions through Entrepreneurship

Pharmacy Is Right For Me

There are so many different types of careers within the field of pharmacy—from research and drug development to pharmacy informatics! To highlight some of the more unique career settings in the industry, we’re introducing a new page on our website— Novel Pharmacy Practice Settings —where you can explore these unique career pathways. In addition to learning more about unique pathways on our new webpage, we’ll also be featuring pharmacists who work in these unique settings on our blog.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Woman of the Week: Dr. Lauren Lazar

PharmaVoice

As Calcium’s medical director, Lazar is leveraging next-generation innovation to create strategic connections between science and marketing for healthcare brands.

130
130
article thumbnail

Medicare Advantage plans brace for final controversial risk adjustment rule by Feb. 1

Fierce Healthcare

Medicare Advantage plans brace for final controversial risk adjustment rule by Feb.

126
126

More Trending

article thumbnail

Payer startup Angle Health scores $58M to scale operations, expand to new markets

Fierce Healthcare

Payer startup Angle Health scores $58M to scale operations, expand to new markets agliadkovskaya Wed, 01/25/2023 - 09:42

125
125
article thumbnail

Moderna now in the crosshairs of Sens. Warren, Welch over price tag for COVID vaccine

Fierce Pharma

Moderna now in the crosshairs of Sens.

Vaccines 122
article thumbnail

State-by-state licensure is anachronistic in the age of teletherapy, providers say

Fierce Healthcare

State-by-state licensure is anachronistic in the age of teletherapy, providers say aburky Wed, 01/25/2023 - 14:52

116
116
article thumbnail

Merck's Keytruda dealt another blow in prostate cancer but readies new challenge to AZ's Imfinzi

Fierce Pharma

Merck's Keytruda dealt another blow in prostate cancer but readies new challenge to AZ's Imfinzi aliu Wed, 01/25/2023 - 10:17

113
113
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Kroger enters clinical trial business

Drug Store News

Kroger Health has established a clinical trial site network to increase reach and access to research studies.

112
112
article thumbnail

EMA validates first regulatory submission for CRISPR-based medicine

European Pharmaceutical Review

The European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for exagamglogene autotemcel (exa-cel), the first regulatory submission for a CRISPR-based medicine. Through the validation, exa-cel is indicated for the treatment of sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). The MAA from Vertex Pharmaceuticals and CRISPR Therapeutics is supported by two global Phase III studies.

Labelling 111
article thumbnail

Health system hospitals, physicians deliver 'marginally' better care at higher cost than independent peers: study

Fierce Healthcare

Health system hospitals, physicians deliver 'marginally' better care at higher cost than independent peers: study dmuoio Wed, 01/25/2023 - 13:52

Hospitals 105
article thumbnail

DTx for women’s mental health – Woebot and postpartum depression

pharmaphorum

Digital therapeutics company Woebot Health has announced enrolment of the first patient in a pivotal clinical trial to evaluate the safety and efficacy of WB001, an investigational therapeutic for postpartum depression (PPD), granted Breakthrough Device designation by the US Food and Drug Administration (FDA) in 2021. The double-blind, randomised, controlled trial will evaluate WB001, a Software as a Medical Device (SaMD) based Cognitive Behavioural Therapy (CBT) program for the treatment of mil

FDA 105
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Is WHO ready to end the global health emergency over Covid? Maybe not just yet

STAT

Three years ago, the World Health Organization declared that the mushrooming outbreak of a new coronavirus — later named SARS-CoV-2, the cause of Covid-19 — posed such a threat to global health that it merited designation as a public health emergency of international concern. On Friday, an emergency committee will meet again to deliberate whether the time has come to recommend to WHO Director-General Tedros Adhanom Ghebreyesus that he declare the global health emergency is over.

102
102
article thumbnail

Top 5 All-Time Hypertension Clinical Trials

Med Ed 101

In this article, we lay out our top 5 all-time hypertension clinical trials. If you remember previously, we covered the top 5 landmark clinical trials in hyperlipidemia. It was a tough call with many options, but here’s our list of hypertension clinical trials. Feel free to comment below if you feel we missed one! DASH […] The post Top 5 All-Time Hypertension Clinical Trials appeared first on Med Ed 101.

98
article thumbnail

Opinion: Reinventing health care in 2023

STAT

After a year defined by record inflation and double-digit health care premium increases, I hope that a few years down the road we can eventually look back at 2023 as the year that ignited change in U.S. health care and led to a new system that future generations are proud of. I’ll be doing everything I can to make that happen.

article thumbnail

REX Awards 2023 – Natural Products

Drug Store News

This year’s winners pay homage to legacy brands that have been mainstays in the drug store channel’s natural section as well as new brands that have created a name for themselves.

98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: Vir CEO George Scangos to retire, after pandemic success

STAT

Vir Biotechnology CEO George Scangos said on Wednesday he will retire, ending an itinerant, nearly 40-year-career as one of biotech’s most recognizable executives. Scangos, 74, will be succeeded in April by Marianne De Backer , a longtime pharma executive who currently heads pharmaceutical strategy at Bayer. She will inherit a company that rose to prominence during the pandemic by developing the antibody drug sotrovimab and is trying to repeat the success with a series of candidates for C

98
article thumbnail

H-E-B broadens Texas footprint

Drug Store News

H-E-B officially opened its store in Cibolo, Texas, the first location for the retailer in the community northeast of San Antonio.

98
article thumbnail

STAT+: Lilly turns to nonprofit, not the FDA, to resolve dispute with Novartis over a prescription drug ad

STAT

In a rare move, the Better Business Bureau National Programs settled a dispute between two big drug companies over a prescription drug ad, suggesting the nonprofit may take a larger role in resolving complaints that might normally be handled by the U.S. Food and Drug Administration. The dispute began when Eli Lilly challenged some of the information in an ad that Novartis had run for its Kisqali breast cancer treatment.

FDA 98
article thumbnail

Walmart to raise wages, offer other incentives for associates

Drug Store News

Walmart announced four initiatives to support its associates, including offering higher wages.

98
article thumbnail

Automating – and optimising – HCP engagement to maximise commercial success

pharmaphorum

Life sciences marketing has rapidly evolved to mirror that of consumer retail. There are now more ways than ever to interact with customers, from traditional channels like email and phone calls to more modern approaches like social media and texting, and new ways to engage customers are emerging every year. So, how can companies maximise the effectiveness of customer engagement strategies when there are so many digital and physical mediums of interaction to choose from?

article thumbnail

STAT+: Focused exclusively on life sciences, three top investors set out on their own

STAT

Almost a year ago, three top investors at Lux Capital and Obvious Ventures announced they were leaving the firms, teasing on Twitter that they were starting “something new.” That something is a new venture capital firm, which launched Wednesday with $350 million for its first fund.

98
article thumbnail

CVS Health launches Virtual Primary Care, expands access to mental health support

Drug Store News

The virtual care program is now available nationwide to Aetna commercial members enrolled in eligible fully insured and self-insured health plans.

article thumbnail

STAT+: Novartis is fined by Belgian regulators for anticompetitive practices over an eye treatment

STAT

Belgian antitrust regulators fined Novartis nearly $2.8 million for making misleading statements about a treatment for a serious eye disease, the latest instance in which the company was cited by a government for anticompetitive practices in connection with the medication. The fine is only the latest act in a long-running drama over Lucentis, which is used to treat age-related macular degeneration, a common disease among older adults that can lead to blindness.

98
article thumbnail

Joint Committee on Vaccination and Immunisation provides advice on next round of Covid boosters

Hospital Pharmacy Europe

The Joint Committee on Vaccination and Immunisation (JCVI) has advised offering Covid booster vaccinations in spring and autumn 2023 for patients deemed to be at high risk. Interim advice to the UK Government has recommended that planning begin for a 2023 autumn booster programme for those at higher risk of severe Covid-19 because of age or clinical risk factors.

article thumbnail

Ovarian cancer, Olivia, and the OCC – part one

pharmaphorum

Following the European Society of Gynaecological Oncology (ESGO) 2022 congress, pharmaphorum spoke with experts from among the Ovarian Cancer Commitment (OCC) founding partners – ESGO, the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe), and AstraZeneca – all of which had been involved in the development of Olivia: a new digital and dedicated support resource for people affected by ovarian cancer through all stages of the disease.

article thumbnail

STAT+: The 4 biggest questions about the FDA’s forthcoming changes to accelerated approvals

STAT

WASHINGTON — Congress just boosted the FDA’s authority over the post-market clinical trials that are a condition of speedy drug approvals, and industry lobbyists are anxious to know how the agency plans to wield that new power, which includes criminal prosecution. The Food and Drug Administration’s accelerated approval program is popular with patients who want treatments for life-threatening conditions as soon as possible.

FDA 98
article thumbnail

9 benefits of weight management

The Checkup by Singlecare

If you’ve decided it’s time to lose the extra weight you’ve been carrying around, here’s some motivation: You can experience a number of health benefits from just a modest amount of weight loss. Losing just 5% to 10% of your total body weight can help you sleep better at night, maintain better control over your blood sugar levels, and lower your risk of cardiovascular disease, according to the Centers for Disease Control and Prevention (CDC).

article thumbnail

STAT+: Pharmalittle: Merck ends late-stage trial for Keytruda in prostate cancer; doctor group says 60 Minutes segment on Wegovy was an ad

STAT

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite the cloudy skies looming over the Pharmalot campus. After all, the birds are still chirping and a tolerable breeze is wafting by. Moreover, this marks the middle of the week, which means we have managed to survive this far. And this calls for celebration, yes? So please join us as we hoist another cup of delicious stimulation.

98
article thumbnail

Murad brings dermatological, pharmaceutical approach to eczema care

Drug Store News

Drug Store News spoke to Howard Murad, a board-certified dermatologist, pharmacist and founder of Murad Skincare, about the brand’s new Eczema Control line and how it caters to all consumers.

98
article thumbnail

Use of herbicide glyphosate associated with elevated biomarkers of oxidative DNA damage

Hospital Pharmacy Europe

Glyphosate is commonly used as a herbicide and a study in farmers has observed positive associations with biomarkers of oxidative DNA damage Regular use by farmers of the herbicide glyphosate is linked with higher levels of urinary biomarkers of oxidative stress and which represents a key characteristic of carcinogens, according to a study by US researchers.